BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37945798)

  • 1. The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer.
    Di Giorgio C; Bellini R; Lupia A; Massa C; Urbani G; Bordoni M; Marchianò S; Rosselli R; De Gregorio R; Rapacciuolo P; Sepe V; Morretta E; Monti MC; Moraca F; Cari L; Ullah KRS; Natalizi N; Graziosi L; Distrutti E; Biagioli M; Catalanotti B; Donini A; Zampella A; Fiorucci S
    Cell Oncol (Dordr); 2024 Apr; 47(2):695-710. PubMed ID: 37945798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving SRC Signaling in Gastric Cancer.
    Zhang X; Soutto M; Chen Z; Bhat N; Zhu S; Eissmann MF; Ernst M; Lu H; Peng D; Xu Z; El-Rifai W
    Gastroenterology; 2022 Sep; 163(3):620-636.e9. PubMed ID: 35588797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
    Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
    Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.
    Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C
    Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.
    Zhang W; Shi X; Chen R; Zhu Y; Peng S; Chang Y; Nian X; Xiao G; Fang Z; Li Y; Cao Z; Zhao L; Liu G; Sun Y; Ren S
    Mol Ther; 2020 Nov; 28(11):2473-2487. PubMed ID: 32592689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.
    Morton SD; Cadamuro M; Brivio S; Vismara M; Stecca T; Massani M; Bassi N; Furlanetto A; Joplin RE; Floreani A; Fabris L; Strazzabosco M
    Oncotarget; 2015 Sep; 6(28):26052-64. PubMed ID: 26296968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.
    Di Giorgio C; Marchianò S; Marino E; Biagioli M; Roselli R; Bordoni M; Bellini R; Urbani G; Zampella A; Distrutti E; Donini A; Graziosi L; Fiorucci S
    Front Oncol; 2022; 12():939969. PubMed ID: 35847866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers.
    Yu S; Li Q; Wang Y; Cui Y; Yu Y; Li W; Liu F; Liu T
    Exp Cell Res; 2021 Sep; 406(1):112734. PubMed ID: 34265288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free LIF receptor α-chain distal cytoplasmic motifs enhance Jak2-independent STAT3 phosphorylation and induce differentiation in HL-60 cells.
    Sun Q; Wang J; Xiong J; Yang L; Liu H
    Oncol Rep; 2011 Aug; 26(2):399-404. PubMed ID: 21567092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.
    Takahashi Y; Takahashi M; Carpino N; Jou ST; Chao JR; Tanaka S; Shigeyoshi Y; Parganas E; Ihle JN
    Mol Endocrinol; 2008 Jul; 22(7):1673-81. PubMed ID: 18451094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel oncogenic mutation of FGFR4 in gastric cancer.
    Futami T; Kawase T; Mori K; Asaumi M; Kihara R; Shindoh N; Kuromitsu S
    Sci Rep; 2019 Oct; 9(1):14627. PubMed ID: 31601997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
    Kurdi M; Booz GW
    J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes.
    Broholm C; Brandt C; Schultz NS; Nielsen AR; Pedersen BK; Scheele C
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E283-92. PubMed ID: 22649064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.
    Liu S; Gandler HI; Tošić I; Ye DQ; Giaccone ZT; Frank DA
    Mol Cancer Res; 2021 Aug; 19(8):1283-1295. PubMed ID: 33931487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
    Metz S; Naeth G; Heinrich PC; Müller-Newen G
    J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIF-JAK1-STAT3 signaling delays contact inhibition of human corneal endothelial cells.
    Liu X; Tseng SC; Zhang MC; Chen SY; Tighe S; Lu WJ; Zhu YT
    Cell Cycle; 2015; 14(8):1197-206. PubMed ID: 25695744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling.
    Quaglino A; Schere-Levy C; Romorini L; Meiss RP; Kordon EC
    Breast Cancer Res; 2007; 9(5):R69. PubMed ID: 17925034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer.
    Ye Y; Jiang D; Li J; Wang M; Han C; Zhang X; Zhao C; Wen J; Kan Q
    Tumour Biol; 2016 Mar; 37(3):3185-95. PubMed ID: 26432329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
    Hu L; Cong L
    Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.